Fisher Asset Management LLC Sells 601,868 Shares of Veradigm Inc. (NASDAQ:MDRX)

Fisher Asset Management LLC trimmed its holdings in shares of Veradigm Inc. (NASDAQ:MDRXFree Report) by 21.0% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 2,264,275 shares of the software maker’s stock after selling 601,868 shares during the period. Fisher Asset Management LLC owned approximately 2.07% of Veradigm worth $23,752,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Swiss National Bank raised its stake in shares of Veradigm by 1.0% in the third quarter. Swiss National Bank now owns 240,200 shares of the software maker’s stock worth $3,156,000 after acquiring an additional 2,300 shares during the last quarter. Charles Schwab Investment Management Inc. raised its stake in shares of Veradigm by 12.3% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,916,406 shares of the software maker’s stock worth $25,182,000 after acquiring an additional 210,137 shares during the last quarter. PNC Financial Services Group Inc. raised its stake in shares of Veradigm by 2.7% in the third quarter. PNC Financial Services Group Inc. now owns 32,052 shares of the software maker’s stock worth $421,000 after acquiring an additional 836 shares during the last quarter. Covestor Ltd raised its stake in shares of Veradigm by 10.3% in the third quarter. Covestor Ltd now owns 10,336 shares of the software maker’s stock worth $136,000 after acquiring an additional 966 shares during the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of Veradigm in the third quarter worth about $189,000.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on MDRX shares. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $10.00 price target (down from $15.00) on shares of Veradigm in a research note on Tuesday, March 19th. TD Cowen dropped their price target on shares of Veradigm from $26.00 to $15.00 and set a “buy” rating for the company in a research note on Tuesday, May 28th. Finally, StockNews.com started coverage on shares of Veradigm in a research note on Tuesday. They set a “hold” rating for the company. Five research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $12.00.

Get Our Latest Report on MDRX

Veradigm Trading Up 1.6 %

Veradigm stock opened at $9.60 on Wednesday. Veradigm Inc. has a twelve month low of $5.01 and a twelve month high of $14.09. The company has a 50 day moving average of $8.27 and a 200-day moving average of $8.72.

About Veradigm

(Free Report)

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Further Reading

Want to see what other hedge funds are holding MDRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veradigm Inc. (NASDAQ:MDRXFree Report).

Institutional Ownership by Quarter for Veradigm (NASDAQ:MDRX)

Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.